POINT - Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain

Chronic Pain Clinical Trial

— POINT  

Official title:

Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05828121
• Other study ID #: POINTstavanger
• Status: Recruiting
• Phase: N/A
• Start date: October 1, 2022
• Est. completion date: June 1, 2025

Study information

• Verified date: April 2023
• Source: Helse Stavanger HF
• Contact: Kine Gjesdal, PhD
• Phone: 004748136702
• Email: kine.gjesdal[@]sus.no
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators do research on chronic pain treatment to minimize the risks associated with opioids.

Description:

The investigators know that patients suffering from chronic pain need good treatment. The use of opioids for chronic, non-cancer related pain may seem appropriate in the short term, but can often have negative consequences for both the individual and society in the long term.

Several factors-the escalating use of opioids to chronic pain patients, the increasing use of strong opioids in particular, and the increasing number of overdoses caused by prescription opioids-point to the start of an opioid epidemic in Norway.

Objectives The overall goal of the POINT project is to provide knowledge to optimize treatment of patients with chronic pain in order to avoid unnecessary escalation of opioid treatment, improve their quality of life and reduce the burden of disease.

In the long run our objective is to prevent the unwanted consequences of opioid treatment and improve patients' quality of life.

Ultimately, through this project the investigators hope to prevent an opioid epidemic in Norway.

To achieve the main goal, the investigators will focus on pain patients and their doctors, as increasing opioid use may occur through the patient-doctor interaction.

Methods

The project will develop and test a non-drug interventions that consist of an interdisciplinary group treatment .

Financing The Research Council of Norway

Cooperation St. Olavs Hospital

Stavanger Hospital Trust

City of Stavanger

National Institute of Public Health (FHI)

Alcohol and Drug Research Western Norway (KoRFor)

Foreningen for kroniske smertepasienter (FKS) Norwegian Forum of Disabled Peoples' Organizations (SAFO)

Cooperation with other projects Injury Prevention and Outcomes following Trauma

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 90
• Est. completion date: June 1, 2025
• Est. primary completion date: June 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 67 Years

Eligibility

Inclusion Criteria:

• non-malignant, chronic pain

• Registered in Stavanger municipality

• Consent to participation.

• Age 18 - 67 years

• Pain duration <10 years

Exclusion Criteria:

• malignant pain condition

Related Conditions & MeSH terms

• Chronic Pain
• Opioid Use

Intervention

Behavioral:
• POINT1
Receiving treatment

Locations

Country	Name	City	State
Norway	Stavanger municipality	Stavanger

Sponsors (2)

Lead Sponsor	Collaborator
Helse Stavanger HF	The Research Council of Norway

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change From Baseline in Audit C at 12 Weeks	Audit C	12 weeks
Primary	Change from baseline in Pain Scores on the Visual Analog Scale at 12 Weeks	Visual Analog Scale	12 weeks
Primary	Change from baseline in Bergen Insomnia scale at 12 Weeks	BIS	12 weeks
Primary	Change from baseline in Health-related quality of life at 12 Weeks	HQ5D5L	12 weeks